Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Cash & Current Investments (2023 - 2025)

Zhengye Biotechnology Holding has reported Cash & Current Investments over the past 3 years, most recently at $7.3 million for Q4 2025.

  • Quarterly Cash & Current Investments rose 161.86% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, up 161.86% year-over-year, with the annual reading at $7.2 million for FY2025, 161.22% up from the prior year.
  • Cash & Current Investments was $7.3 million for Q4 2025 at Zhengye Biotechnology Holding, up from $6.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $7.3 million in Q4 2025 and troughed at $2.8 million in Q4 2024.
  • The 3-year median for Cash & Current Investments is $5.3 million (2023), against an average of $5.2 million.
  • Year-over-year, Cash & Current Investments decreased 29.3% in 2024 and then surged 161.86% in 2025.
  • A 3-year view of Cash & Current Investments shows it stood at $3.9 million in 2023, then fell by 29.3% to $2.8 million in 2024, then surged by 161.86% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Cash & Current Investments are $7.3 million (Q4 2025), $6.6 million (Q2 2025), and $2.8 million (Q4 2024).